Gambaran Umum
Virios Therapeutics is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ('FM').
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Dogwood Therapeutics, Inc. per 2025 Jun 30 adalah -18.20 MM.
- Nilai net income untuk Dogwood Therapeutics, Inc. per 2025 Jun 30 adalah -24.74 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -18.20 | -24.74 | |
2025-03-31 | -15.34 | -21.98 | |
2024-12-31 | -12.23 | -12.35 | |
2024-09-30 | -5.82 | -5.73 | |
2024-06-30 | -4.80 | -4.68 | |
2024-03-31 | -5.20 | -5.07 | |
2023-12-31 | -5.45 | -5.30 | |
2023-09-30 | -6.40 | -6.24 | |
2023-06-30 | -7.72 | -7.58 | |
2023-03-31 | -9.91 | -9.80 | |
2022-12-31 | -12.32 | -12.25 | |
2022-09-30 | -14.41 | -14.71 | |
2022-06-30 | -15.93 | -16.25 | |
2022-03-31 | -16.54 | -16.86 | |
2021-12-31 | -15.64 | -15.96 | |
2021-09-30 | -17.88 | -17.95 | |
2021-06-30 | -16.43 | -16.56 | |
2021-03-31 | -12.68 | -12.94 | |
2020-12-31 | -10.01 | -10.35 | |
2020-09-30 | -4.15 | -4.48 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -19.87 | -19.87 |
2024-12-31 | -12.52 | |
2024-09-30 | -6.42 | -6.42 |
2024-06-30 | -5.81 | -5.81 |
2024-03-31 | -6.67 | -6.67 |
2023-12-31 | -7.05 | |
2023-09-30 | -8.40 | -8.40 |
2023-06-30 | -11.77 | -11.77 |
2023-03-31 | -18.06 | -18.06 |
2022-12-31 | -27.66 | |
2022-09-30 | -43.02 | -43.23 |
2022-06-30 | -48.76 | -48.86 |
2022-03-31 | -50.61 | -50.71 |
2021-12-31 | -47.90 | -48.00 |
2021-09-30 | -59.44 | -59.32 |
2021-06-30 | -62.04 | -62.04 |
2021-03-31 | -55.75 | -55.75 |
2020-12-31 | -52.50 | |
2020-09-30 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Dogwood Therapeutics, Inc. per 2025 Jun 30 adalah -15.75 MM.
- Nilai cash from investing activities untuk Dogwood Therapeutics, Inc. per 2025 Jun 30 adalah 3.76 MM.
- Nilai kas dari aktivitas pendanaan untuk Dogwood Therapeutics, Inc. per 2025 Jun 30 adalah 22.50 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -15.75 | 3.76 | 22.50 |
2025-03-31 | -12.54 | 3.76 | 24.08 |
2024-12-31 | -8.79 | 3.76 | 16.70 |
2024-09-30 | -4.13 | 1.38 | |
2024-06-30 | -4.18 | 2.61 | |
2024-03-31 | -4.11 | 1.16 | |
2023-12-31 | -4.87 | 1.16 | |
2023-09-30 | -6.07 | 1.07 | |
2023-06-30 | -7.60 | 4.49 | |
2023-03-31 | -10.51 | 4.49 | |
2022-12-31 | -11.47 | 4.49 | |
2022-09-30 | -13.97 | 4.58 | |
2022-06-30 | -14.14 | 0.00 | |
2022-03-31 | -13.23 | 0.00 | |
2021-12-31 | -15.69 | -0.10 | |
2021-09-30 | -12.80 | 31.49 | |
2021-06-30 | -10.71 | 31.49 | |
2021-03-31 | -8.73 | 32.12 | |
2020-12-31 | -3.90 | 33.38 | |
2020-09-30 | -2.08 | 2.37 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah 0.11.
- p/tbv untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -0.31.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.11 | -0.31 | |
2025-03-31 | 0.17 | 0.21 | |
2024-12-31 | 1.22 | 1.22 | |
2024-09-30 | -0.82 | 1.50 | 1.50 |
2024-06-30 | -0.70 | 0.94 | 0.94 |
2024-03-31 | -0.67 | 0.75 | 0.75 |
2023-12-31 | -0.57 | 0.75 | 0.75 |
2023-09-30 | -0.45 | 0.58 | 0.58 |
2023-06-30 | -0.49 | 0.62 | 0.62 |
2023-03-31 | -0.37 | 0.50 | 0.50 |
2022-12-31 | -0.23 | 0.37 | 0.37 |
2022-09-30 | -0.25 | 0.40 | 0.40 |
2022-06-30 | -0.10 | 0.16 | 0.16 |
2022-03-31 | -0.10 | 0.11 | 0.11 |
2021-12-31 | -0.10 | 0.09 | 0.09 |
2021-09-30 | -0.09 | 0.09 | 0.09 |
2021-06-30 | -0.10 | 0.07 | 0.07 |
2021-03-31 | -0.13 | 0.06 | 0.06 |
2020-12-31 | -0.16 | 0.06 | 0.06 |
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -0.20.
- EBIT (3 tahun) / EV untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -0.11.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.20 | -0.11 |
2025-03-31 | -0.14 | -0.11 |
2024-12-31 | -3.23 | -4.38 |
2024-09-30 | -3.39 | -5.27 |
2024-06-30 | -4.27 | -8.91 |
2024-03-31 | -21.22 | -44.74 |
2023-12-31 | 5.11 | 10.63 |
2023-09-30 | 6.63 | 11.77 |
2023-06-30 | 8.51 | 15.11 |
2023-03-31 | 5.81 | 7.82 |
2022-12-31 | 2.30 | 1.94 |
2022-09-30 | 2.39 | 2.02 |
2022-06-30 | 2.69 | 1.95 |
2022-03-31 | 1.74 | 1.11 |
2021-12-31 | 1.29 | 0.78 |
2021-09-30 | 1.02 | 0.47 |
2021-06-30 | 0.82 | 0.35 |
2021-03-31 | 0.69 | 0.31 |
2020-12-31 | 0.43 | 0.21 |
2020-09-30 |
Efektivitas Manajemen
- roa untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -6.05.
- roe untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -8.28.
- roic untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -0.22.
- croic untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah 0.15.
- ocroic untuk Dogwood Therapeutics, Inc. pada 2025 Jun 30 adalah -0.13.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -6.05 | -8.28 | -0.22 | 0.15 | -0.13 |
2025-03-31 | -3.83 | -3.24 | -0.15 | -0.03 | -0.05 |
2024-12-31 | -1.37 | -1.20 | -1.83 | -0.88 | -1.32 |
2024-09-30 | -1.09 | -1.20 | -1.83 | -0.50 | -1.33 |
2024-06-30 | -0.78 | -0.69 | -1.33 | -0.78 | -1.08 |
2024-03-31 | -0.63 | -0.72 | -1.11 | -0.78 | -1.02 |
2023-12-31 | -0.57 | -0.68 | -1.31 | -1.05 | -1.28 |
2023-09-30 | -0.84 | -0.71 | -1.27 | -0.52 | -1.27 |
2023-06-30 | -0.84 | -0.71 | -1.27 | -0.52 | -1.27 |
2023-03-31 | -0.78 | -0.68 | -1.34 | -0.82 | -1.43 |
2022-12-31 | -0.73 | -0.78 | -1.60 | -1.02 | -1.51 |
2022-09-30 | -0.73 | -0.78 | -1.60 | -1.02 | -1.51 |
2022-06-30 | -0.68 | -0.71 | -1.52 | -1.32 | -1.32 |
2022-03-31 | -0.60 | -0.62 | -1.16 | -0.91 | -0.91 |
2021-12-31 | -0.51 | -0.53 | -0.85 | -0.84 | -0.83 |
2021-09-30 | -22.86 | -0.95 | 0.99 | -0.68 | |
2021-06-30 | -13.02 | -0.72 | 0.91 | -0.47 | |
2021-03-31 | -40.95 | -0.41 | 0.75 | -0.28 | |
2020-12-31 | -32.75 | -0.30 | 0.86 | -0.11 | |
2020-09-30 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1818844 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |